← All diseases

Blood and immune system diseases

TNF receptor-associated periodic syndrome (TRAPS)

An inherited inflammatory disease with long-lasting attacks of fever. During attacks there is muscle pain, abdominal pain and a rash.

Not part of the panel of Türkiye's National Newborn Screening Programme (heel-prick test). Source

This page is translated from the Turkish original.

This disease is followed through the “Blood and immune system diseases” group.

Understanding the disease

This section has not yet been reviewed by a physician. It summarises patient information from sources such as MedlinePlus, Orphanet and the NHS in plain language. The disease can differ from person to person; talk to your doctor about diagnosis and treatment.

What happens in this disease?

A change in the TNFRSF1A gene causes a protein called TNF receptor 1 to fold incorrectly. This protein builds up inside the cell and constantly stimulates inflammation. As a result, attacks of fever and inflammation happen without any germs. Attacks usually last 1 to 3 weeks.

Which symptoms can occur?

The first attack usually happens in childhood. Symptoms may include:

  • Repeated, long-lasting fever (common)
  • Muscle pain spreading to the arms and legs
  • A red, painful rash that spreads
  • Abdominal pain, nausea and vomiting
  • Swelling around the eyes or eye inflammation
  • Joint and chest pain
  • Build-up of a protein called amyloid in the kidneys (sometimes)

How is it diagnosed?

The doctor suspects TRAPS based on the symptoms and family history. During attacks, inflammation markers rise in the blood. The diagnosis is confirmed with a genetic test of the TNFRSF1A gene. The urine is also checked for protein.

Treatment and care

Anti-inflammatory medicines and cortisone can be used to ease attacks. Biological medicines that block a substance called IL-1, which starts inflammation, can clearly reduce attacks. There is an approved biological treatment for this disease. People on treatment need regular blood and urine tests. The doctor who follows the disease decides which treatment is suitable.

For the family: inheritance and genetic counselling

Inheritance is dominant. For each child of an affected parent, the chance is 1 in 2. Not everyone who carries the gene may become ill. Sometimes the gene change is new. Genetic counselling is recommended for family members with similar complaints.

Source: MedlinePlus Genetics: Tumor necrosis factor receptor-associated periodic syndrome · NORD: Tumor Necrosis Factor Receptor-Associated Periodic Syndrome · PRINTO/PReS: TNF Reseptörüyle İlişkili Periyodik Sendrom (TRAPS)

Key facts

How common is it?
Prevalence: 1-9 per 1 000 000 (Europe)
How is it inherited?
Autosomal dominant
When does it usually start?
Adolescence, Adulthood, Childhood, Infancy
Gene(s) involved
TNFRSF1A

These facts are taken from Orphanet and MedlinePlus records (last checked: October 7, 2026). Frequency values are approximate ranges.

You are not alone: patient associations in Türkiye

Non-profit patient and family organizations in Türkiye working on this disease or disease group. Links are for information; Doktorclub is not affiliated with these organizations and does not endorse them.

For all rare diseases: Nadir Hastalıklar Federasyonu

Links checked on October 8, 2026.

Support and help

Doktorclub does not diagnose, recommend treatments or refer you to hospitals or doctors. These pages are meant to help you talk with your doctor.

News about TRAPS

Clinical trials (ClinicalTrials.gov)

A clinical trial is a regulated study that tests whether a new treatment is safe and whether it works, in patients who volunteer. Most trials look for a certain age, genetic change and health condition. Taking part is voluntary.

This list is not a treatment recommendation. Treatments tested in phase 1–3 trials are investigational (experimental): their efficacy and safety have not yet been proven and they are not approved treatments. Taking part depends on each trial’s criteria and a physician’s assessment; the first step is to talk to the doctor who manages your care.

ClinicalTrials.gov currently lists no active interventional studies for this disease. Last checked: October 7, 2026.

See all studies on ClinicalTrials.gov · Joining clinical trials

Blood and immune system diseases: other news

Medical codes (for talking with your doctor and finding sources)

These codes identify the disease in international classifications and databases. They can help when you talk with your doctor or look for reliable sources.

Orphanet code: ORPHA:32960 · ICD-11 4A60.2

Codes checked against WHO ICD-11 and Orphanet on October 7, 2026.

This page provides general information and does not replace diagnosis or treatment. Talk to your doctor about symptoms, diagnosis and treatment.

The information on these pages is for general information only and does not replace medical advice. Talk to your doctor about diagnosis and treatment decisions. In an emergency in Türkiye, call 112.

Every update is based on an open source and labeled with its level of evidence. No advertising and no drug brand names. Our scientific principles

This page was translated from Turkish by the Doktorclub editorial team.